FAM
BIO icon

Formidable Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Formidable Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,464
Closed -$701K – 299
2023
Q1 		$701K Buy
1,464
+531
+57% +$249K 0.15% 134
2022
Q4 		$392K Hold
933
– – 0.09% 192
2022
Q3 		$389K Buy
933
+22
+2% +$11K 0.09% 186
2022
Q2 		$451K Buy
911
+15
+2% +$7.81K 0.1% 179
2022
Q1 		$505K Buy
896
+56
+7% +$33.8K 0.1% 183
2021
Q4 		$635K Buy
840
+84
+11% +$62.9K 0.12% 156
2021
Q3 		$564K Buy
+756
New +$566K 0.11% 182

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return